---
title: "Pfizer Inc. Stock Underperforms Thursday When Compared To Competitors Despite Daily Gains"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/288771322.md"
description: "Pfizer Inc. (PFE) shares rose 1.38% to $25.69 on Thursday, snapping a three-day losing streak amid broader market gains. However, the stock underperformed compared to key competitors like Johnson & Johnson, Eli Lilly, and Abbott Laboratories, which saw larger percentage increases. Pfizer remains 10.63% below its 52-week high of $28.75. Trading volume was lower than the 50-day average."
datetime: "2026-06-04T20:36:41.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/288771322.md)
  - [en](https://longbridge.com/en/news/288771322.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/288771322.md)
---

# Pfizer Inc. Stock Underperforms Thursday When Compared To Competitors Despite Daily Gains

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of Pfizer Inc. (PFE) advanced 1.38% to $25.69 Thursday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index rising 0.41% to 7,584.31 and the Dow Jones Industrial Average rising 1.73% to 51,561.93.

The stock's rise snapped a three-day losing streak.

Pfizer Inc. closed 10.63% below its 52-week high of $28.75, which the company achieved on April 2nd.

The stock underperformed when compared to some of its competitors Thursday, as Johnson & Johnson (JNJ) rose 2.21% to $228.17, Eli Lilly & Co. (LLY) rose 4.31% to $1,125.27, and Abbott Laboratories (ABT) rose 4.36% to $90.78.

Trading volume (30.5 M) remained 4.6 million below its 50-day average volume of 35.1 M.

Data source: Dow Jones Market Data, FactSet. Data compiled June 4, 2026.

This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.

(END) Dow Jones Newswires

06-04-26 1636ET

### Related Stocks

- [PFE.US](https://longbridge.com/en/quote/PFE.US.md)
- [.SPX.US](https://longbridge.com/en/quote/.SPX.US.md)
- [.DJI.US](https://longbridge.com/en/quote/.DJI.US.md)
- [JNJ.US](https://longbridge.com/en/quote/JNJ.US.md)
- [LLY.US](https://longbridge.com/en/quote/LLY.US.md)
- [ABT.US](https://longbridge.com/en/quote/ABT.US.md)

## Related News & Research

- [<![CDATA[Chai Discovery Enters License Agreement with Pfizer to Accelerate Drug Discovery with AI]]>](https://longbridge.com/en/news/288873963.md)
- [Pfizer Says FDA Approves Expanded HYMPAVZI Indication For Hemophilia A And B](https://longbridge.com/en/news/289046752.md)
- [Wall Street Predicts GitLab Stock Will Soar 110%. Here’s Why.](https://longbridge.com/en/news/288966234.md)
- [US FDA approves Pfizer's bleeding disorder drug for children](https://longbridge.com/en/news/289042377.md)
- [Clear Harbor Asset Management LLC Acquires 95,532 Shares of Pfizer Inc. $PFE](https://longbridge.com/en/news/288231231.md)